Quest Diagnostics Aktie

Kaufen
Verkaufen
145,30 EUR +0,15 EUR +0,10 %
153,63 USD +2,10 USD +1,39 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 16,24 Mrd. EUR

KGV 18,33 Div. Rendite 2,06%

WKN 904533

ISIN US74834L1008

Symbol DGX


Quest Diagnostics Aktie Analyse

23.07.10 Quest Diagnostics outperform RBC Capital Markets
22.07.10 Quest Diagnostics neutral Credit Suisse Group
22.07.10 Quest Diagnostics neutral UBS AG
19.07.10 Quest Diagnostics overweight Barclays Capital
08.07.10 Quest Diagnostics halten UBS AG
26.04.10 Quest Diagnostics kaufen Barclays Capital
21.10.09 Quest Diagnostics neutral Credit Suisse Group
16.09.09 Quest Diagnostics neutral Credit Suisse Group
22.07.09 Quest Diagnostics outperform Credit Suisse Group
22.04.09 Quest Diagnostics outperform Credit Suisse Group
22.04.09 Quest Diagnostics hold Jefferies & Company Inc.
01.04.08 Quest Diagnostics neutral Cowen and Company, LLC
29.02.08 Quest Diagnostics outperform Credit Suisse Group
07.12.07 Quest Diagnostics neutral Cowen and Company, LLC
16.08.07 Quest Diagnostics neutral Credit Suisse Group
07.06.07 Quest Diagnostics buy UBS
17.04.07 Quest Diagnostics neutral Banc of America Sec.
29.01.07 Quest Diagnostics Overweight JP Morgan
01.09.06 Quest Diagnostics neutral UBS
04.08.06 Quest Diagnostics Outperform Piper Jaffray
25.07.06 Quest Diagnostics hold Jefferies & Co
29.06.06 Quest Diagnostics Hold Matrix Research
02.05.06 Quest Diagnostics Buy Rochdale Securities
21.04.06 Quest Diagnostics Strong Buy UBS
01.11.05 Quest Diagnostics buy JP Morgan
28.09.05 Quest Diagnostics positive Susquehanna Financial
27.09.05 Quest Diagnostics Positive Susquehanna Financial
07.06.05 Quest Diagnostics Neutral Sun Trust Robinson Humphrey
30.03.05 Quest Diagnostics Net Neutral Susquehanna Financial
12.01.05 Quest Diagnostics Overweight Lehman Brothers
07.01.05 Quest Diagnostics Neutral JP Morgan
07.01.05 Quest Diagnostics Neutral JP Morgan